Check Artelo Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.6M
EPS (TTM)
-7.29
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-7.4M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
270180600.00%
Compare market cap, revenue, PE, and other key metrics of Artelo Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.6M | -93.58% | NA | 0.00% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Artelo Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Artelo Biosciences Inc investment value today
Current value as on today
₹89,802
Returns
Returns from Artelo Biosciences Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Artelo Biosciences Inc. Average target price of $18
Get share price movements and forecasts by analysts on Artelo Biosciences Inc.
What analysts predicted
68.89%UPSIDE
Target Price
$18
Current Price
$5.6
Analyzed by
9 Analysts
Target
$18.00
Artelo Biosciences Inc target price $18, a slight upside of 68.89% compared to current price of $5.6. According to 9 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 67.3% return, outperforming this stock by 94.6%
Against Peers
In the last 3 years, Beone Medicines Ltd has given 114.6% return, outperforming this stock by 193.4%
Price Dip
In the last 7 days, ARTL stock has moved down by -7.5%
Organisation | Artelo Biosciences Inc |
Headquarters | 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075 |
Industry | Catalog/Specialty Distribution |
CEO | Mr. Gregory D. Gorgas M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Gregory D. Gorgas M.B.A. | President, CEO, Treasurer, Secretary & Director |
Mr. Mark E. Spring | Chief Financial Officer |
Dr. Andrew Yates Ph.D. | Senior VP & Chief Scientific Officer |
Dr. Steven D. Reich M.D. | Chief Medical Officer |
Mr. Jason H. Baybutt | Senior Vice President of Finance |
Artelo Biosciences Inc share price today is $5.6 as on at the close of the market. Artelo Biosciences Inc share today touched a day high of $5.71 and a low of $4.85.
Artelo Biosciences Inc share touched a 52 week high of $28.6 on and a 52 week low of $4.2 on . Artelo Biosciences Inc stock price today i.e. is closed at $5.6,which is 80.42% down from its 52 week high and 33.33% up from its 52 week low.
Artelo Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Artelo Biosciences Inc (ARTL) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Artelo Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Artelo Biosciences Inc share’s latest price of $5.6 as on September 19, 2025 at 1:29 am IST, you will get 1.7857 shares of Artelo Biosciences Inc. Learn more about
fractional shares .
Artelo Biosciences Inc stock has given -93.58% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?